Daratumumab vs pomalidomide for the treatment of relapsed/refractory multiple myeloma: A cost-effectiveness analysis

被引：10
作者：
Gong, Cynthia L. [1 ]
Studdert, Ann L. [1 ]
Liedtke, Michaela [2 ]
机构：
[1] Stanford Ctr High Value Care, Stanford, CA USA
[2] Stanford Univ, Med Ctr, Stanford Canc Inst, Stanford, CA 94305 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 03期
关键词：
OPEN-LABEL;
D O I：
10.1002/ajh.25372
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E68 / E70
页数：3
相关论文
共 6 条
[1]  
[Anonymous], MULT MYEL VERS 3 201
[2]   Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States [J].
Carlson, Josh J. ;
Guzauskas, Gregory F. ;
Chapman, Richard H. ;
Synnott, Patricia G. ;
Liu, Shanshan ;
Russo, Elizabeth T. ;
Pearson, Steven D. ;
Brouwer, Elizabeth D. ;
Ollendorf, Daniel A. .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (01) :29-+
[3]   Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial [J].
Lonial, Sagar ;
Weiss, Brendan M. ;
Usmani, Saad Z. ;
Singhal, Seema ;
Chari, Ajai ;
Bahlis, Nizar J. ;
Belch, Andrew ;
Krishnan, Amrita ;
Vescio, Robert A. ;
Victoria Mateos, Maria ;
Mazumder, Amitabha ;
Orlowski, Robert Z. ;
Sutherland, Heather J. ;
Blade, Joan ;
Scott, Emma C. ;
Oriol, Albert ;
Berdeja, Jesus ;
Gharibo, Mecide ;
Stevens, Don A. ;
LeBlanc, Richard ;
Sebag, Michael ;
Callander, Natalie ;
Jakubowiak, Andrzej ;
White, Darrell ;
de la Rubia, Javier ;
Richardson, Paul G. ;
Lisby, Steen ;
Feng, Huaibao ;
Uhlar, Clarissa M. ;
Khan, Imran ;
Ahmadi, Tahamtan ;
Voorhees, Peter M. .
LANCET, 2016, 387 (10027) :1551-1560
[4]   Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold [J].
Neumann, Peter J. ;
Cohen, Joshua T. ;
Weinstein, Milton C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (09) :796-797
[5]   Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed-refractory Multiple Myeloma in the United States [J].
Pelligra, Christopher G. ;
Parikh, Kejal ;
Guo, Shien ;
Chandler, Conor ;
Mouro, Jorge ;
Abouzaid, Safiya ;
Ailawadhi, Sikander .
CLINICAL THERAPEUTICS, 2017, 39 (10) :1986-2005
[6]   Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial [J].
San Miguel, Jesus ;
Weisel, Katja ;
Moreau, Philippe ;
Lacy, Martha ;
Song, Kevin ;
Delforge, Michel ;
Karlin, Lionel ;
Goldschmidt, Hartmut ;
Banos, Anne ;
Oriol, Albert ;
Alegre, Adrian ;
Chen, Christine ;
Cavo, Michele ;
Garderet, Laurent ;
Ivanova, Valentina ;
Martinez-Lopez, Joaquin ;
Belch, Andrew ;
Palumbo, Antonio ;
Schey, Stephen ;
Sonneveld, Pieter ;
Yu, Xin ;
Sternas, Lars ;
Jacques, Christian ;
Zaki, Mohamed ;
Dimopoulos, Meletios .
LANCET ONCOLOGY, 2013, 14 (11) :1055-1066
1